ZOETIS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 169 USD | +0.54% |
|
+1.18% | -14.35% |
| May. 08 | HSBC Adjusts Price Target on Zoetis to $225 From $230 | MT |
| May. 06 | BNP Paribas Exane Adjusts Price Target on Zoetis to $232 From $237 | MT |
ETFs positioned on Zoetis Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 6.87% | 1 M€ | -.--% | ||
| 3.35% | 0 M€ | +7.69% | - | |
| 2.04% | 36 M€ | +22.19% | ||
| 2.01% | 0 M€ | +8.40% | - | |
| 1.75% | 4,592 M€ | +11.18% | ||
| 1.44% | 10 M€ | +6.14% | - | |
| 1.35% | 0 M€ | +11.36% | - | |
| 1.00% | 9 M€ | -.--% | - | |
| 0.88% | 2 M€ | +20.44% | ||
| 0.82% | 3,859 M€ | +18.82% | ||
| 0.82% | 469 M€ | -2.05% | ||
| 0.77% | 0 M€ | +5.49% | - | |
| 0.67% | 92 M€ | +0.06% | - | |
| 0.65% | 5 M€ | -72.95% | - | |
| 0.54% | 0 M€ | +8.06% | ||
| 0.53% | 29 M€ | -.--% | - | |
| 0.53% | 322 M€ | +13.88% | ||
| 0.52% | 414 M€ | +11.90% | - | |
| 0.52% | 1,006 M€ | -.--% | ||
| 0.49% | 2 M€ | +21.73% | - | |
| 0.48% | 1,448 M€ | -.--% | - | |
| 0.48% | 219 M€ | +17.17% | - | |
| 0.44% | 0 M€ | +12.85% | ||
| 0.44% | 330 M€ | -.--% | ||
| 0.44% | 2 M€ | +14.69% | - | |
| 0.40% | 0 M€ | +9.27% |
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows:
- pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%);
- livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%);
- other (1.1%).
Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%).
At the end of 2022, the group has 29 production sites worldwide.
The United States accounts for 53.4% of net sales.
Sector
Pharmaceuticals
Calendar
2024-05-22
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
169
USD
Average target price
211
USD
Spread / Average Target
+24.82%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -14.35% | 77.13B | |
| +14.09% | 8.4B | |
| -0.70% | 3.22B | |
| +14.70% | 1.64B | |
| -10.12% | 1.5B | |
| -22.60% | 1.3B | |
| -4.20% | 1.25B | |
| -10.26% | 1.18B | |
| +5.06% | 1.1B | |
| -12.05% | 950M |
- Stock Market
- Equities
- ZTS Stock
- Funds and ETFs Zoetis Inc.